Metoclopramide Injection, USP 10 mg (5mg/mL), 2 mL Single-dose Vial, Rx Only, Sterile, Hospira Inc., Lake Forest, IL, 60045, USA, NDC 0409-3414-01
Published November 27, 2013 · Recall initiated: September 24, 2013
Summary
FDA records drug Class II recall D-012-2014, published November 27, 2013 and initiated September 24, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 251,400 vials; Lot: Lot #: 28-104-DK*, Exp 10/01/2014 (* lot number may be proceeded with an 01). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: Potential vendor glass issue - glass spiticules (glass strands) were identified during site inspection of the vials.
What to do
Voluntary: Firm initiated · Letter
Get an email if METOCLOPRAMIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- METOCLOPRAMIDE
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot #: 28-104-DK*, Exp 10/01/2014 (* lot number may be proceeded with an 01)
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMetoclopramide Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals,November 4, 2026
- FDAMetoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: TevaOctober 21, 2026
- FDAMetoclopramide Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only, Distributed by: American Health Packaging,October 21, 2026
- FDAMetoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska,July 2, 2025
- FDASpironolactone tablets, USP 50 mg, Rx only, 100 count bottle, Distributed By: Greenstone LLC, Peapack, NJNovember 27, 2013
- FDAOndansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL Single-dose Vial, Rx Only, Sterile, Hospira Inc., LakeNovember 27, 2013
Questions about this recall
Was Metoclopramide Injection, USP 10 mg (5mg/mL), 2 mL Single-dose Vial, Rx Only, Sterile, Hospira Inc., Lake Forest, IL, 60045, USA, NDC 0409-3414-01 recalled?
Yes. FDA published recall D-012-2014 on November 27, 2013. Reported hazard: Presence of Particulate Matter: Potential vendor glass issue - glass spiticules (glass strands) were identified during site inspection of the vials.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: METOCLOPRAMIDE.